Zobrazeno 1 - 10
of 213
pro vyhledávání: '"S I, Glukhova"'
Autor:
A. O. Mikhailina, O. S. Kostareva, E. A. Aseeva, S. I. Glukhova, A. M. Lila, S. V. Tishchenko
Publikováno v:
Современная ревматология, Vol 18, Iss 4, Pp 74-79 (2024)
The search for new biomarkers for the early diagnosis of systemic lupus erythematosus (SLE) is a crucial task. Objective: a comparative study of concentrations of conservative protein nucleobindin 1 (NUCB1) in the blood serum of patients with SLE and
Externí odkaz:
https://doaj.org/article/bf2c58607ce5456ea78357614c570247
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 3, Pp 309-318 (2024)
Juvenile idiopathic arthritis (JIA) is characterized by a high risk of joint destruction, extra-articular changes, and rapidly progressive disability. The CHAQ (Childhood Health Assessment Questionnaire) questionnaire and X-ray are often used to asse
Externí odkaz:
https://doaj.org/article/6d89f5e033eb4787891bf469880e28de
Autor:
Е. Е. Gubar, Т. V. Korotaeva, Т. V. Dubinina, L. D. Vorobyeva, Р. О. Tremaskina, Е. М. Agafonova, Yu. L. Korsakova, Е. Yu. Loginova, К. V. Sakharova, А. О. Sablina, А. V. Smirnov, S. F. Erdes, М. М. Urumova, S. I. Glukhova
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 2, Pp 168-175 (2024)
Objective – to compare clinical characteristics of patients with axial spondyloarthritis (axSpA)/ankylosing spondylitis (AS) and with axial psoriatic arthritis (axPsA).Subjects and methods. 100 patients were examined: 45 – with axSpA/AS (group 1)
Externí odkaz:
https://doaj.org/article/2f8988d39f8a4850a7375454736d431d
Autor:
E. Yu. Loginova, P. O. Tremaskina, E. E. Gubar, T. V. Korotaeva, A. V. Sukhinina, S. I. Glukhova
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 1, Pp 98-103 (2024)
Objective – to assess the dynamics of the sacroiliac joint radiographic progression (X-SIJ) in early psoriatic arthritis (ePsA).Methods. 32 patients (pts) (19 men and 13 women) with PsA were examined at baseline (BL) and after 7 years. Mean age –
Externí odkaz:
https://doaj.org/article/246be38854b749d68520ad34381cedfd
Autor:
P. S. Kovalenko, I. S. Dydykina, O. G. Alekseeva, E. L. Shakhramanova, A. S. Potapova, S. I. Glukhova, E. G. Zotkin
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 84-91 (2023)
Ensuring a long-lasting effect of the therapy and its safety are important tasks in the treatment of patients with osteoarthritis (OA). Parenteral forms of chondroitin sulfate (CS) used for the background therapy of OA are characterized by proven eff
Externí odkaz:
https://doaj.org/article/53ac33443b234510b3b1bc9b3f05bb62
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 31-37 (2023)
Objective: to analyze factors associated with the achievement of acceptable health-related quality of life (HRQoL) in patients with psoriatic arthritis (PsA) 7 years after the start of observation.Material and methods. The study included 53 patients
Externí odkaz:
https://doaj.org/article/7d3112878bd74a2198416d4c59511e0a
Autor:
L. D. Vorobyova, T. V. Korotaeva, S. I. Glukhova, E. Yu. Loginova, E. E. Gubar, Yu. L. Korsakova
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 38-43 (2023)
Objective: to search predictors of achieving minimal disease activity (MDA) during therapy in patients with psoriatic arthritis (PsA).Materials and methods. The study included 41 patients, predominantly men (58.9 %), with a confirmed PsA diagnosis an
Externí odkaz:
https://doaj.org/article/f857b5d534b247328361d4bbdb84c89d
Autor:
T. M. Reshetnyak, E. A. Aseeva, A. A. Shumilova, N. Yu. Nikishina, S. I. Glukhova, S. Yu. Shkireeva, A. M. Lila
Publikováno v:
Современная ревматология, Vol 18, Iss 2 (2024)
Objective: to evaluate the efficacy and safety of the type I interferon (IFN) receptor inhibitor anifrolumab (AFM, Safnelo®) in patients with systemic lupus erythematosus (SLE) in real-life clinical practice over an observation period of 6 months.Ma
Externí odkaz:
https://doaj.org/article/38fb602ba54c47b28b5841d42f364be9
Publikováno v:
Современная ревматология, Vol 17, Iss 5, Pp 43-52 (2023)
Comorbid diseases and adverse events that occur in patients with rheumatoid arthritis (RA) negatively affect the outcomes of RA (radiological progression, joint function, the occurrence of low-energy fractures, thrombotic events, etc.). Objective: to
Externí odkaz:
https://doaj.org/article/f83cdce796b949c090f3c72d2f59ccf0
Autor:
E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, Yu. L. Korsakova, S. I. Glukhova, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 5, Pp 584-589 (2023)
Background. Remission/low disease activity (LDA) are acceptable goal of psoriatic arthritis (PsA) treatment. Prognostic factors for non-remission/LDA hasn’t been fully studied yet and data is limited. The aim – to determine the prognostic factors
Externí odkaz:
https://doaj.org/article/0268bab1785347bca74abf5ef1eb1f57